Advisory Committee Will Dig Into Alzheimer’s Drug Donanemab Next Month

After enduring several setbacks, Lilly will pitch its antiamyloid contender donanemab to the Peripheral and Central Nervous System Advisory Committee in a June 10 meeting.
Source: Drug Industry Daily